Jyske Realkredit A/S
Final terms for bonds to be listed 11th March 2025
Final terms for bonds to be listed 11th March 2025
To Nasdaq Copenhagen A/S 10th March 2025
Announcement no. 22/2025
Final terms for bonds to be listed 11th March 2025
On 11th March 2025, Jyske Realkredit A/S will be listing new Covered Bonds (SDO). Final terms for the bonds are attached to this announcement.
The full prospectus for the Bonds consist of the attached final terms and the previously disclosed ”Base Prospectus for the issue of Covered Bonds (SDO), Mortgage bonds (“RO”) and Mortgage Bonds (RO) and bonds issued pursuant to Section 15 of the Danish Mortgage-Credit Loans and Mortgage-Credit Bonds etc. Act (Section 15 Bonds).”, dated June 28th, 2024.
Jyske Realkredit’s base prospectus is available on Jyske Realkredit’s home page jyskerealkredit.com
Yours sincerely,
Jyske Realkredit A/S
www.jyskerealkredit.com
Please observe that the Danish version of this announcement prevails.
Attachments
- DK0009417198 - Final terms series 422.E.OA Cb3 ju.29 RF
- DK0009417271 - Final terms series G422.E.OA Cb3 ju29 RF
Documents
Subscribe to releases from Globenewswire
Subscribe to all the latest releases from Globenewswire by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from Globenewswire
Rapala VMC Oyj10.3.2025 17:15:00 CET | Press release
Rapala VMC Corporation - Managers' transactions - Oy Rosaco Ab
Smith & Nephew UK Ltd10.3.2025 16:00:00 CET | Press release
Smith+Nephew to highlight breakthrough Sports Medicine technologies for joint repair at AAOS 2025
Orion Oyj10.3.2025 16:00:00 CET | Press release
Orion Corporation: Disclosure Under Chapter 9 Section 10 of the Securities Market Act (BlackRock, Inc.)
Royal UNIBREW A/S10.3.2025 15:58:52 CET | Press release
Share buy-back program
Genmab A/S10.3.2025 15:13:07 CET | Press release
Genmab Announces Johnson & Johnson Decision Regarding HexaBody®-CD38
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.
Visit our pressroom